logo

Medical Device Standard Interpretation

YY/T 1874-2023 EMC Test Protocols for Active Implantable Medical Devices

This page interprets YY/T 1874-2023, EMC test protocols for active implantable medical devices, with a focus on implantable cardiac pacemakers, implantable cardioverter defibrillators, and cardiac resynchronization devices. It covers the regulatory background, device scope, core EMC test items, clinical environment protection requirements, manufacturer documentation obligations, and the main differences from YY 9706.102-2021.

Standard YY/T 1874-2023
Devices Pacemaker / ICD / CRT
Adoption ISO 14117:2019, IDT
Use Case Regulatory Interpretation and Test Planning

Overview

YY/T 1874-2023 is a dedicated EMC test protocol for implantable cardiac devices. It spans critical electromagnetic environments from DC to 3 GHz and is intended to verify that pacemakers, ICDs, CRT-P devices, and CRT-D devices maintain basic safety and essential function under realistic electromagnetic exposure conditions.

Implementation Date 2024-05-01

Registration dossiers and type test packages should be organized against the new standard requirements.

Frequency Coverage 0Hz-3GHz

It covers low-frequency magnetic fields, RFID, wireless communication, and high-frequency radiated field scenarios.

Core Device Scope 4 Device Types

The main target categories are pacemakers, ICDs, CRT-P, and CRT-D devices.

Adoption Relationship IDT

The standard is identically adopted from ISO 14117:2019, which helps align domestic and international test logic.

The focus is not whether the device interferes with others

Unlike general medical EMC standards, YY/T 1874-2023 is primarily concerned with whether an implantable device is falsely triggered, inhibited, reconfigured, or permanently damaged by external electromagnetic fields. The emphasis is the stability of the implanted device itself.

The patient electromagnetic environment keeps getting more complex

Mobile phones, RFID, EAS gates, metal detectors, MRI systems, RF surgery, and wireless charging systems all introduce exposure conditions that directly shape the evolution of this standard.

Why this matters directly to manufacturers

If your product is an implantable pacemaker, defibrillator, or cardiac resynchronization therapy device, EMC is not merely a supplement to a general medical electrical standard. It becomes a core requirement tied to registration compliance, clinical safety, and completeness of the accompanying documentation.

Part 1: Standard Profile and Drafting Background

This section helps teams quickly confirm the standard attributes, regulatory significance, and its relationship with ISO 14117:2019 so they can establish a basic framework for test planning and registration documentation.

ItemContent
Standard No.YY/T 1874-2023
Chinese Title有源植入式医疗器械 电磁兼容 植入式心脏起搏器、植入式心律转复除颤器和心脏再同步器械的电磁兼容测试细则
English TitleActive implantable medical devices - Electromagnetic compatibility - EMC test protocols for implantable cardiac pacemakers, implantable cardioverter defibrillators and cardiac resynchronization devices
Release Date2023-03-14
Implementation Date2024-05-01
Issuing AuthorityNational Medical Products Administration
AdoptionISO 14117:2019, IDT

1.1 Regulatory and registration significance

  • Although it is an industry standard, it carries strong practical regulatory weight because it applies to life-sustaining implantable cardiovascular devices.
  • From May 1, 2024 onward, relevant registration submissions should include EMC test reports aligned with this standard.
  • The standard is under the active implantable devices subcommittee of the national technical committee for surgical implants and orthopedic devices.

1.2 Drafting bodies and industry representation

  • The primary drafting organization is the Shanghai Institute of Medical Device Testing.
  • Participating organizations include major manufacturers such as Medtronic, BIOTRONIK, and leading domestic cardiac rhythm device companies.
  • The drafting process reflects regulatory, laboratory, and manufacturer perspectives at the same time.
1.3

Why this standard is needed

The electromagnetic environment faced by implantable cardiac devices is far more complex than that of general medical electrical equipment. At the low-frequency end, the exposure sources include EAS, RFID, metal detectors, MRI systems, and wireless charging systems. At the high-frequency end, the exposure sources include mobile phones, radios, and other handheld wireless transmitters. If the device experiences inhibition, inappropriate therapy, parameter drift, or permanent damage in those scenarios, the consequences may directly threaten patient life.

Revision TopicDetails
New definitionsAdded terms such as interference mode and transient exposure
Frequency boundary changeThe boundary between conducted injection and radiated testing was shifted from 450 MHz to 385 MHz
New Clause 4.10Introduced transient exposure requirements from 16.6 Hz to 167 kHz
Recognition of multi-pole lead systemsFormally recognizes IS-4, DF-4, and other multi-port, multi-electrode systems
New Clause 7.4Requires disclosure of minimum separation distances from handheld transmitters

Part 2: Scope and Device Classification

The applicability boundary of YY/T 1874-2023 determines not only whether a test item applies, but also how unipolar and bipolar settings, grouping logic, interface circuits, and evaluation criteria should be selected.

Frequency RangeDescription
0 Hz ≤ f < 385 MHzCovers power-frequency magnetic fields, low-frequency induction, RFID, EAS systems, and wireless charging related scenarios
385 MHz ≤ f ≤ 3000 MHzTargets mobile phones, radios, and other handheld wireless communication sources

2.1 Device categories covered

  • Implantable cardiac pacemakers
  • Implantable cardioverter defibrillators
  • Cardiac resynchronization therapy pacemakers
  • Cardiac resynchronization therapy defibrillators

2.2 Different from newer wireless implant platforms

This standard mainly addresses pulse generators used with transvenous or epicardial lead systems. For products such as S-ICD or leadless pacemakers that do not use conventional lead structures, manufacturers should adapt the test logic according to the device architecture.

Device TypeGroupingDescription
Single-channel unipolar deviceGroup aThe tip end is connected to output terminal D and the can is connected to the enclosure port
Multi-channel unipolar deviceGroup bEach channel is connected in turn to the output terminal for multi-chamber unipolar systems
Single-channel bipolar deviceGroup cTip and ring are connected to their respective outputs and both common-mode and differential-mode tests apply
Multi-channel bipolar deviceGroup dApplies to multi-chamber, multi-port bipolar systems
ConfigurationLoop AreaTypical Test LevelDescription
Unipolar sensingLarge, typically referenced to 225 cm²100% test levelLarge loop area means stronger coupling and a more severe worst-case condition
Bipolar sensingAbout 10% of unipolar10% test levelThe shorter tip-to-ring distance significantly reduces induced voltage

Part 3: Detailed Review of Core Test Items

The main body of the standard consists of dedicated EMC tests built around frequency ranges, fault modes, and function-specific device risks. The emphasis is not on general emission limits, but on whether the device can continue to deliver correct therapy during exposure.

ClauseTest ItemFrequency RangePurpose
4.2Induced current in electrode leads0-140 kHzEvaluates whether induced current in the leads exceeds safety limits
4.3Protection against continuous fault from ambient fields16.6 Hz-10 MHzVerifies functional integrity under sustained exposure
4.4Short-duration CW exposure0 Hz-10 MHzObserves recovery behavior and fault risk after brief continuous-wave exposure
4.5EMI sensed as cardiac signals0 Hz-10 MHzPrevents pacing inhibition, inappropriate tracking, and false ICD therapy
4.6 / 4.7Static magnetic field protection0 HzEvaluates the effect of 1 mT and 50 mT static magnetic field exposure
4.8AC magnetic field exposure protection1 kHz-140 kHzCovers RFID, wireless charging, and induction heating applications
4.9Radiated high-frequency field test385 MHz-3 GHzEvaluates the effect of mobile phones and other wireless devices
4.10Transient exposure test16.6 Hz-167 kHzVerifies transient response under pulsed or intermittent magnetic fields

3.1 Induced lead current testing

This test is based on the principle of electromagnetic induction. It looks at whether low-frequency magnetic fields passing through the lead loop create induced currents above the allowable limit. A 225 cm² planar semicircular reference loop is commonly used as a conservative maximum-coupling condition.

3.2 Continuous fault versus short-duration exposure

Clause 4.3 is more concerned with inhibition, irreversible parameter changes, or loss of function during exposure lasting tens of seconds to minutes. Clause 4.4 emphasizes transient anomalies caused by second-level exposure and the device ability to recover afterward. Together they describe the practical EMC resilience of the implant.

Frequency RangeUnipolar LimitBipolar LimitApplicable Port
0-140 Hz100 mA10 mASensing / pacing port
140 Hz-1 kHz100 mA10 mASensing / pacing port
1 kHz-10 kHz100 mA10 mASensing / pacing port
10 kHz-140 kHz100 mA10 mASensing / pacing port
0-140 kHz50 mA50 mACardioversion / defibrillation port
Frequency RangeUnipolar Test AmplitudeBipolar Test AmplitudeScenario
16.6 Hz-1 kHz1000 mV peak100 mV peakProtection against continuous ambient-field fault
1 kHz-10 kHz1000 mV peak100 mV peakProtection against continuous ambient-field fault
10 kHz-100 kHz500 mV peak50 mV peakProtection against continuous ambient-field fault
100 kHz-1 MHz200 mV peak20 mV peakProtection against continuous ambient-field fault
1 MHz-10 MHz100 mV peak10 mV peakProtection against continuous ambient-field fault

3.3 Focus of radiated RF field testing

  1. The frequency span is 385 MHz to 3 GHz, mainly simulating handheld wireless devices such as mobile phones.
  2. For pacemaker mode, pacing interval deviation should remain within 10% of the programmed rate.
  3. For ICD and CRT-D modes, no inappropriate shock or anti-tachycardia therapy is allowed.

3.4 Why transient exposure matters

  1. The new clause responds directly to the growth of intermittent magnetic field applications such as wireless charging and inductive systems.
  2. The evaluation is not limited to continuous exposure. It also considers pulse duty cycle, phase relationship, and short-duration shock response.
  3. Annex O provides example methods for evaluating transient and permanent fault behavior in CIEDs.

Part 4: Special Protection Requirements in Clinical Environments

Clause 6 specifically addresses high-risk exposure scenarios in clinical practice, including high-frequency electrosurgery and external defibrillation. These tests correspond to some of the most severe electromagnetic shocks encountered in hospitals.

4.1 High-frequency electrosurgery exposure

  • The scenario covers electrosurgical knives, RF ablation, electrocautery, and related high-frequency medical systems.
  • The main risk is that high-frequency current travels through tissue and induces overload in the lead system.
  • The acceptance criteria focus on appearance, function, parameter retention, and abnormal heating risk.

4.2 External defibrillation exposure

  • Defibrillation pulses may reach 2000 V with peak current in the tens of amperes.
  • Direct risks include circuit overload, memory loss, and breakdown of sensitive components.
  • Indirect risks include pacing-threshold change, sensing reset, and the need for device reprogramming.
Test ItemTypical Parameter / ConditionAcceptance Criteria
High-frequency electrosurgery exposureSimulated surgical-frequency current to evaluate lead and circuit protectionNo visible damage, full function retained, parameters unchanged, no abnormal heating
External defibrillation exposureTypical biphasic waveform, 2000 V, 30 A peak, 10-20 msDevice function retained, no need for re-adjustment, battery status normal

EMC risk in clinical environments is more complex than in the lab

Interference in hospitals is not always a stable continuous field. It may combine high-energy pulses, coupling through metallic instruments, changes in lead routing, and variability in patient physiology. The value of Clause 6 is therefore not simply that it adds two more tests, but that it brings key clinical risks into the pre-market verification stage.

Part 5: Manufacturer Documentation and Test Equipment Requirements

YY/T 1874-2023 does not stop at laboratory testing. It also requires manufacturers to disclose sufficient EMC risk information in the instructions for use and technical documents so clinicians and patients can use the device appropriately.

Documentation RequirementDescription
Permanent programmable sensitivity settingsProgrammable options and default values should be stated so users understand EMC behavior under different sensitivity settings
Fallback mode descriptionThe manufacturer should describe whether the device may enter noise-following mode, magnetic mode, or backup mode under EMI
Known potentially hazardous behaviorsThe documentation should disclose the electromagnetic field types and scenarios that may cause inhibition, inappropriate therapy, or damage
Minimum distance from handheld transmittersRecommended separation distances for mobile phones, radios, Bluetooth devices, and similar sources should be stated

5.1 Typical separation distance examples

  • Radio at about 1 W: typically 15 to 30 cm
  • Mobile phone at about 0.2 W: typically 15 cm
  • Bluetooth device below 0.1 W: typically 5 cm

5.2 Key test equipment

  • Tissue-equivalent interface circuits and low-pass filters
  • Torso simulators and tissue-equivalent media
  • Dipole antennas, signal generators, oscilloscopes, and power amplifiers
  • Annexes D through O define fixtures, calibration methods, and naming conventions in a systematic way
01

Confirm the device configuration first

Unipolar or bipolar, single-chamber or multi-chamber, pacing mode or defibrillation mode all affect grouping and interface connections.

02

Then confirm programmed sample settings

Use Annex I to choose sensitivity, output, detection, and therapy settings so the test reflects a justified worst-case condition.

03

Prepare documentation disclosures in parallel

Do not leave EMC warnings and separation guidance to the end of the registration cycle. Documentation disclosure is part of compliance itself.

04

Link testing to risk management

Test data should map back to use scenarios, hazardous behaviors, and separation recommendations so the compliance story is complete.

Part 6: Relationship with and Differences from YY 9706.102-2021

Many teams are more familiar with the general medical electrical EMC standard YY 9706.102-2021. However, YY/T 1874-2023 is a typical implant-specific standard, and the two standards do not prioritize the same risks.

Comparison DimensionYY/T 1874-2023YY 9706.102-2021
Object of applicationImplantable pacemakers, ICDs, and CRT devicesGeneral medical electrical equipment and systems
Core concernEffect of external electromagnetic fields on implanted device functionGeneral emission and immunity requirements of medical equipment
Device locationImplanted inside the bodyUsed outside the body
Main riskInhibition, inappropriate therapy, permanent parameter changeInterference to others and loss of essential performance
Base standardISO 14117:2019IEC 60601-1-2

6.1 Why YY 9706.102 alone is not enough

General EMC standards do not sufficiently cover long-lead coupling, microvolt-level sensing, life-support function behavior, or continuous in-body exposure characteristics. If a team only uses general EMC thinking, it may underestimate risks such as EMI being sensed as cardiac signals, overload during external defibrillation, and magnetic-field mode switching.

6.2 How the two standards work together in practice

For systems that include external companion equipment, the implant itself should follow YY/T 1874-2023, while programmers, monitors, and other external devices should still follow YY 9706.102-2021. In practice, the structure is implant-specific standard plus general standard for peripheral equipment, not one instead of the other.

Testing AspectYY/T 1874-2023YY 9706.102-2021
Conducted emissionUsually not the main focusEmission tests on power ports and signal ports
Radiated emissionWeakly emphasized or not a primary focusGeneral emission requirements from 30 MHz to 6 GHz
Radiated immunityEvaluated against implant mode and function-specific criteriaEvaluated against general field strength levels and essential performance
Low-frequency magnetic fieldsStatic field, AC field, and transient exposure are all key itemsUsually limited to power-frequency magnetic field immunity
Special clinical environmentsHigh-frequency surgery and external defibrillation are dedicated clausesNot handled as implant-specific risk scenarios

Appendix: Key Terms, Takeaways, and References

If you want to apply this standard quickly to project kickoff, test planning, and registration discussion, the terms, takeaways, and references below can serve as practical training material for internal teams.

Key takeaways

  • YY/T 1874-2023 is the core dedicated EMC standard for implantable cardiac devices and should not be replaced by general medical EMC logic.
  • The real focus is whether the device can continue to sense correctly, deliver therapy correctly, and maintain stable parameters under complex electromagnetic exposure.
  • Manufacturers must do more than complete laboratory testing. They also need to state known hazardous behaviors and minimum separation distances in the accompanying documents.
  • In project execution, testing, instructions for use, risk management, and registration materials should be treated as one integrated workflow.

Core terminology

TermEnglishMeaning
心脏起搏器PacemakerAn implantable device used to treat bradycardia
植入式心律转复除颤器ICDAn implantable device capable of defibrillation and anti-tachycardia therapy
心脏再同步治疗器械CRTA device intended to improve cardiac function by restoring ventricular synchrony
转换模式Fallback modeA degraded safe operating mode entered by the device under EMI
瞬态暴露Transient exposureAn intermittent or short-duration form of electromagnetic exposure
  1. YY/T 1874-2023, EMC test protocols for implantable cardiac pacemakers, implantable cardioverter defibrillators, and cardiac resynchronization devices
  2. ISO 14117:2019 Active implantable medical devices - Electromagnetic compatibility
  3. GB 16174.1-2015 / ISO 14708-1:2014 General requirements for safety of active implantable medical devices
  4. YY 0989.6-2016 / ISO 14708-6:2010 Particular requirements for implantable defibrillators
  5. YY 9706.102-2021 Medical electrical equipment - Part 1-2: General requirements for basic safety and essential performance - Collateral Standard: Electromagnetic disturbances - Requirements and tests
Tel: 020-2204 2442
E-mail:Sales@greentest.com.cn
微信客服二维码